14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ATRC ranks #14214 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$73.35 (3.19%)

Volume: 220k

Closed: Dec 08, 2021

Hollow Logo Score: -1.093

AtriCure Stock Forecast

$73.35 (3.19%)

Volume: 220k

Closed: Dec 08, 2021

Score Hollow Logo -1.093
Which way will ATRC go? Request
Key Stats
Beta 1.09
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 43 and the stock is currently not being overbought or oversold

Green day on Wednesday for AtriCure
(Updated on Dec 08, 2021)


Sell candidate since 2021-12-08

The AtriCure stock price gained 3.19% on the last trading day (Wednesday, 8th Dec 2021), rising from $71.08 to $73.35. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.33% from a day low at $70.44 to a day high of $74.19. The price has risen in 6 of the last 10 days, but is still down by -2.71% for this period. Volume fell on the last day by -30 thousand shares and in total, 220 thousand shares were bought and sold for approximately $16.16 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect AtriCure stock with a 90% probability to be traded between $63.51 and $87.33 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Signals & Forecast

There are mixed signals in the stock today. The AtriCure stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $74.93. On a fall, the stock will find some support from the short-term average at $67.73. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, November 30, 2021, and so far it has risen 15.69%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $66.00 and $65.53. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AtriCure finds support just below today's level at $66.00. If this is broken, then the next support from accumulated volume will be at $65.53 and $63.40.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.75 between high and low, or 5.33%. For the last week, the stock has had a daily average volatility of 6.09%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is AtriCure stock A Buy?

AtriCure holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.093

Predicted Opening Price for AtriCure of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$72.66 $73.35 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 04, 2021 "Needham & Company LLC" gave "$90.00 - $92.00" rating for ATRC. The price target was set to $82.47+5.2%.

Volatility and Risk
Daily Average Volatility: 6.09 %
Overall Risk: Very High High Medium Low Very Low
Volatility
6.09 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $76.71
Price: $73.35
Support: $66.00

ATRC Insider Trading Show all Trades

INSIDER POWER

0.516

Last 100 transactions
Buy: 395 685 | Sell: 767 466 (Shares)
Date Action Amount Person Type
Nov 12, 2021 Sell 2 732 Austin Tonya Common Stock
Nov 12, 2021 Sell 345 Carrel Michael H Common Stock
Nov 10, 2021 Sell 345 Carrel Michael H Common Stock
Nov 04, 2021 Sell 2 604 Wirick Angela L Common Stock
Nov 04, 2021 Sell 4 000 Collar Mark A Common Stock
Show all Insider Trades
INSIDER POWER

0.516

Last 100 transactions
Buy: 395 685 | Sell: 767 466 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 76.41 4.18 %
74.98 2.22 %
74.09 1.02 %
Current price: 73.35
Support 71.23 -2.89 %
70.34 -4.10 %
68.91 -6.06 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 87.14 18.80 %
85.40 16.43 %
76.71 4.58 %
Current price 73.35
Support 66.00 -10.02%
65.53 -10.66%
63.40 -13.57%

Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally. The company offers Isolator Synergy System and related radio frequency(RF) ablation devices, which include clamps that are used for ablation during open-heart procedures; ablation and sensing unit, a compact power generator that delivers bipolar RF energy to its clamps, multifunctional pens, a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT